БОЛАЛАРДА СУЯК МИНЕРАЛЛАШУВИ ЖАРАЁНИНИНГ БУЗИЛИШИ
Keywords:
Cуяк минераллашуви, болалик остеопорози, рахит, кальций метаболизми, D витамини, суяк денситометриясиAbstract
Ушбу илмий мақолада болалик даврида суяк минераллашуви жараёнининг бузилиши (остеопения, рахит, остеопороз) этиологияси, патогенези, клиник кўринишлари, диагностика усуллари ва замонавий даволаш йўналтиришлари тахлил қилинади. Болалик остеопорозининг эрта аникланмаси ва тўғри даволаш стратегияларининг ишлаб чиқилиши, кейинги ҳаётда қатъий асоратларнинг олдини олиш имконияти муҳокама қилинади.
References
1.Weaver CM, et al. The National Osteoporosis Foundation's position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations. Osteoporos Int. 2016;27(4):1281-1386.
2.Golden NH, Abrams SA. Optimizing bone health in children and adolescents. Pediatrics. 2014;134(4):e1229-e1243.
3.Bianchi ML, et al. Diagnosis and management of osteoporosis in children and adolescents: the European Society for Paediatric Endocrinology evidence-based guidelines. Horm Res Paediatr. 2020;93(1):1-13.
4.Bachrach LK. Diagnosis and treatment of pediatric osteoporosis. Curr Opin Endocrinol Diabetes Obes. 2014;21(6):454-460.
5.Fewtrell MS, et al. Bone mineralization and turnover in preterm infants at 8-12 years of age: the effect of early diet. J Bone Miner Res. 1999;14(5):810-820.
6.Boyce AM, Gafni RI. Approach to the child with fractures. J Clin Endocrinol Metab. 2011;96(7):1943-1952.
7.Saggese G, et al. Vitamin D in childhood and adolescence: an expert position statement. Eur J Pediatr. 2015;174(5):565-576.
8.Munns CF, et al. Global consensus recommendations on prevention and management of nutritional rickets. J Clin Endocrinol Metab. 2016;101(2):394-415.
9.Högler W. Complications of vitamin D deficiency from the foetus to the infant: One cause, one prevention, but who's responsibility? Best Pract Res Clin Endocrinol Metab. 2015;29(3):385-398.
10.Ward LM, et al. A practical guide to the diagnosis and management of osteoporosis in childhood and adolescence. Front Endocrinol (Lausanne). 2020;11:564.
11.Bishop N, et al. Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2013 Pediatric Official Positions. J Clin Densitom. 2014;17(2):275-280.
12.LeBlanc CM, et al. Incident vertebral fractures in children with leukemia during the first four years of therapy. J Clin Oncol. 2014;32(27):3005-3012.
13.Thacher TD, et al. Nutritional rickets around the world: causes and future directions. Ann Trop Paediatr. 2006;26(1):1-16.
14.Simm PJ, et al. Consensus guidelines on the use of bisphosphonate therapy in children and adolescents. J Paediatr Child Health. 2018;54(3):223-233.
15.Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-281.
Szulc P, et al. Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis. Osteoporos Int. 2008;19(12):1683-1704.
16.Gordon CM, et al. Dual energy X-ray absorptiometry interpretation and reporting in children and adolescents: the 2013 ISCD Pediatric Official 17.Positions. J Clin Densitom. 2014;17(2):225-242.
18.Lewiecki EM, et al. 2019 International Society for Clinical Densitometry official positions. J Clin Densitom. 2019;22(4):453-466.
19.Baroncelli GI. Quantitative ultrasound methods to assess bone mineral status in children: technical characteristics, performance, and clinical application. Pediatr Res. 2008;63(3):220-228.
20.Adams JE. Dual-energy X-ray absorptiometry. In: Osteoporosis and Bone Densitometry Measurements. Springer, 2013: 45-57.
21.Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC: National Academies Press; 2011.
22.Pludowski P, et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality—a review of recent evidence. Autoimmun Rev. 2013;12(10):976-989.
23.Behringer M, et al. Effects of weight-bearing activities on bone mineral content and density in children and adolescents: a meta-analysis. J Bone Miner Res. 2014;29(2):467-478.
24.Sbrocchi AM, et al. The use of bisphosphonates in children: review of the literature and guidelines for dental management. J Can Dent Assoc. 2014;80:e6.
25.Hoyer-Kuhn H, et al. Two years' experience with denosumab for children with osteogenesis imperfecta type VI. Orphanet J Rare Dis. 2014;9:145.
26.Lindsay R, et al. Teriparatide for osteoporosis: importance of the full course. Osteoporos Int. 2016;27(8):2395-2410.
27. Holick, M. F. Vitamin D deficiency. // New England Journal of Medicine. – 2007. – Vol. 357. – P. 266-281.
28.Tushiya, N. E., et al. MicroRNAs: Novel Regulators of Bone Metabolism. // Bone Research. – 2018. – Vol. 6. – Article 10.
29.Taipale, A. et al. Epigenetics and Bone Health: The Role of MicroRNAs. // Endocrine Reviews. – 2021. – Vol. 42(3). – P. 315-340.
30.Zhao, H. et al. miR-21 promotes osteoblast differentiation and bone formation in rats. // Osteoporosis International. – 2017. – Vol. 28. – P. 2001-2010.
31.Wang, X., et al. miR-148a enhances osteoclast differentiation and promotes bone resorption. // Journal of Bone and Mineral Research. – 2016. – Vol. 31(1). – P. 195–204.
32.Soyarslan, G. et al. Bone mineral density in children: current perspectives. // Journal of Clinical Research in Pediatric Endocrinology. – 2019. – Vol. 11(3). – P. 209-216.
33.Shils, M. E., Shike, M. Modern Nutrition in Health and Disease. – 11th ed. – Lippincott Williams & Wilkins, 2014.
34.Ашрапова, А. А. Д витаминининг гормонал регуляция механизми. – Т.: Тиббиёт нашриёти, 2023. – 180 б.
